By expenditures
| Name | Title | Type |
|---|---|---|
| Angel Landrau | Finance Director | Auditee |
| Paula Hodges | Partner | Auditee |
| Paula Hodges | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 339573 | 2024 | 2025-01-23 | Martin Starnes & Associates CPAS P A | $16.79M |
| 15443 | 2023 | 2024-02-05 | Martin Starnes & Associates CPAS P A | $18.38M |
| 41619 | 2022 | 2023-01-17 | Martin Starnes & Associates CPAS P A | $24.30M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 339573 | 2024 | 2025-01-23 | 1096517 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 1096516 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 1096515 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 1096514 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 1096513 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 1096512 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 520075 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 520074 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 520073 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 520072 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 520071 | 2024-001 | Significant Deficiency | - | N |
| 339573 | 2024 | 2025-01-23 | 520070 | 2024-001 | Significant Deficiency | - | N |
| 41619 | 2022 | 2023-01-17 | 622345 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622344 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622343 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622342 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622341 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622340 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622339 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622338 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622337 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622336 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622335 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 622334 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45903 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45902 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45901 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45900 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45899 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45898 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45897 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45896 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45895 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45894 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45893 | 2022-001 | Significant Deficiency | - | NP |
| 41619 | 2022 | 2023-01-17 | 45892 | 2022-001 | Significant Deficiency | - | NP |